XML 37 R26.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisitions (Tables)
 9 Months Ended
Sep. 30, 2016
Business Combinations [Abstract]  
Schedule of Business Acquisitions, by Acquisition
The aggregate consideration to acquire Synageva consisted of:
Stock consideration
$
4,917,810

Cash consideration
4,565,524

Total purchase price
$
9,483,334
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the estimated fair values of assets acquired and liabilities assumed:
Cash
$
626,217

Inventory
23,880

In-process research and development (IPR&D)
4,236,000

Deferred tax liabilities, net
(159,991
)
Other assets and liabilities
(26,143
)
Net assets acquired
4,699,963

Goodwill
4,783,371

Total purchase price
$
9,483,334
Business Acquisition, Pro Forma Information
The following unaudited pro forma information presents the combined results of Alexion and Synageva as if the acquisition of Synageva had been completed on January 1, 2014, with adjustments to give effect to pro forma events that are directly attributable to the acquisition. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that would have had we completed the transaction on January 1, 2014.
 
Three months ended
 
Nine months ended
 
September 30, 2015
 
September 30, 2015
Pro forma revenue
$
666,637

 
$
1,905,388

Pro forma net loss
(177,854
)
 
(47,565
)
Loss per common share
 
 
 
     Basic
$
(0.79
)
 
$
(0.21
)
     Diluted
$
(0.79
)
 
$
(0.21
)
Schedule of Acquisition Related Costs
Acquisition-related costs associated with our business combinations for the three and nine months ended September 30, 2016 and 2015 include the following:
 
Three months ended
 
Nine months ended
 
September 30,
 
September 30,
 
2016
 
2015
 
2016
 
2015
Transaction costs (1)
$
—

 
$
—

 
$
375

 
$
26,799

Integration costs
—

 
6,075

 
1,938

 
9,053

 
$
—

 
$
6,075

 
$
2,313

 
$
35,852

 
 
 
 
 
 
 
 
(1) Transaction costs include investment advisory, legal, and accounting fees
 
For the three and nine months ended September 30, 2015, the acquisition of Synageva resulted in $3,149 and $13,470 of restructuring related charges, respectively. Synageva restructuring related charges were not material for the three and nine months ended September 30, 2016. See Note 18 for additional details.